tiprankstipranks
Percheron Therapeutics (AU:PER)
ASX:PER
Australian Market
PER
Percheron Therapeutics
RESEARCH TOOLSreports
Want to see AU:PER full AI Analyst Report?

Percheron Therapeutics (PER) Stock News & Sentiment

13 Followers
Percheron Therapeutics Updates Market on Lapse of 600,000 Options
Premium
Company Announcements
Percheron Therapeutics Updates Market on Lapse of 600,000 Options
21d ago
Percheron secures funding and key conference slots to advance HMBD-002 into phase II
Premium
Company Announcements
Percheron secures funding and key conference slots to advance HMBD-002 into phase II
22d ago
Percheron Therapeutics Issues 131 Million Unquoted Options at $0.01 Exercise Price
Premium
Company Announcements
Percheron Therapeutics Issues 131 Million Unquoted Options at $0.01 Exercise Price
30d ago
Percheron Therapeutics Seeks ASX Quotation for 262.9 Million New Shares
Premium
Company Announcements
Percheron Therapeutics Seeks ASX Quotation for 262.9 Million New Shares
30d ago
Percheron’s VISTA-Targeting Cancer Drug Clears Key Phase I Safety Hurdle
Premium
Company Announcements
Percheron’s VISTA-Targeting Cancer Drug Clears Key Phase I Safety Hurdle
1M ago
Percheron Therapeutics Updates ASX Filing on Unquoted Equity Securities
Premium
Company Announcements
Percheron Therapeutics Updates ASX Filing on Unquoted Equity Securities
1M ago
Percheron Therapeutics Corrects ASX Filing on Unquoted Equity Securities
Premium
Company Announcements
Percheron Therapeutics Corrects ASX Filing on Unquoted Equity Securities
1M ago
More AU:PER News >

PER News on the Web

CEO, MD & Director of Percheron Therapeutics James Garner Buys 40% More Shares
Simply Wall St
Bullish
Percheron Therapeutics Updates ASX Filing on Unquoted Equity Securities
TipRanks News
Bearish
Percheron Therapeutics Corrects ASX Filing on Unquoted Equity Securities
TipRanks News
Neutral
Percheron Therapeutics Issues 27.5 Million Unquoted Options Expiring in 2028
TipRanks News
Bearish
Percheron Therapeutics Issues 50 Million Unquoted Options Expiring in 2028
TipRanks News
Bearish
Percheron Director Increases Stake Through Entitlement Offer
TipRanks News
Bullish
Percheron Therapeutics Issues 86 Million Unquoted Options Expiring 2028
TipRanks News
Neutral
Percheron raises $2.2 million to back phase II push for HMBD-002
Proactive Investors
Bullish

News Score - Last 7 Days

Neutral
AU:PER
Sector Average
Media Buzz
This Week8 articles
Weekly Average3.25 articles
News Sentiment
This Week50%
Sector Average77%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is AU:PER’s Media Buzz Sentiment?
8 articles about AU:PER were published this week. In an average week, 3.25 articles are published.
    What is AU:PER’s weekly average amount of articles?
    In an average week, 3.25 articles about AU:PER are published.
      What is AU:PER’s News Sentiment?
      50% of articles about AU:PER were positive this week, compared to its sector average of 77%.
        Healthcare Stocks that are Trending in the News
        GOSSGossamer Bio
        RLAYRelay Therapeutics
        IMVTImmunovant
        ROIVRoivant Sciences
        PROKProKidney
        Showing the stocks with the most bullish news sentiment over the past week